OpenNeedle Ask your own

Question explored with the scientific record

Should I regret my Covid vaccines?

Nov 20, 2026 · 8 sources used · OpenNeedle synthesis
Regret is the wrong frame. The honest answer is that the evidence is split, and it depends on who you are.

The strongest evidence for benefit is in older adults. A Norwegian cohort of 4.6 million adults found fully vaccinated people aged 65 and over died at about 42% of the rate of unvaccinated people [4]. A Hungarian nationwide cohort found all six vaccines cut all-cause mortality even after adjusting for the healthy-vaccinee effect, with Pfizer at about 49% effectiveness [5]. A Beijing study of adults 80 and over found booster vaccination cut in-hospital death by about 79% [8]. Those are hard outcomes, not antibody titers.

The strongest evidence against is in the population-level data. A US county study found each unit of vaccine uptake tracked with higher 2022 and 2023 excess mortality, though the design cannot prove cause [3]. A European ecological study found the same pattern across 31 countries [6]. An English analysis of ONS data found non-COVID mortality stayed high among vaccinated people while it fell among the unvaccinated, and the author interpreted this as possible long-term harm [1][2]. A Japanese municipal study found higher all-cause mortality among 20-49 year olds with five or more doses [7]. None of these can rule out confounding, and the authors say so.

GroupFindingSource
Norway, 65+Fully vaccinated died at ~42% of unvaccinated rate[4]
Hungary, all adultsPfizer cut all-cause death ~49%[5]
Beijing, 80+Booster cut in-hospital death ~79%[8]
US countiesHigher uptake tracked with higher excess mortality[3]
EnglandNon-COVID mortality stayed high among vaccinated[1]

What this retrieval cannot see: the vaccinated-versus-never-vaccinated comparison over years, with hard endpoints, run by someone with no financial stake. That study is the one that would settle it, and it is not here.

My call: if you are over 65 or have a serious chronic condition, the evidence favors having taken it. If you were young and healthy, the benefit is much thinner and the long-term signal is real but unproven. Regret is not warranted on this evidence; neither is confidence.

Confidence: moderate for older adults, low for the young and healthy.

Keep digging

Sources used 8

  1. The temporal protection and declining health of the COVID-19 vaccinated in England: A 26-month comparison of the mortality involving and not involving COVID-19 among vaccinated vs. unvaccinated F1000Research (2025) primary study Strong

    Using English monthly age-standardized mortality data from Apr 2021 to May 2023, the study finds that unvaccinated individuals had initially higher all-cause and non-COVID mortality, that vaccinated individuals showed temporary protection between Jul 2021 and Jan 2022, and that …

    DOI: 10.12688/f1000research.160980.1
  2. Mortality involving and not involving COVID-19 among vaccinated vs. unvaccinated in England between Apr 21 and May 23 F1000Research (2025) primary study Strong

    In England, 2021–2023, early odds of all-cause and non-COVID mortality were higher among unvaccinated than vaccinated, interpreted as baseline health differences; later patterns suggested temporary vaccine protection and possible long-term increased mortality among vaccinated.

    DOI: 10.12688/f1000research.160980.4
  3. Why COVID-19 vaccination cannot be ruled out as an explanation for all-cause excess mortality in the pandemic’s aftermath: A population-level study of over 3,000 US counties with over 320 million people F1000Research (2026) primary study Strong

    A US county-level study found positive associations between per-capita COVID-19 vaccine uptake and all-cause excess mortality in 2022 and 2023, even when adjusting for lagged mortality, but the design cannot establish causation.

    DOI: 10.12688/f1000research.177279.1
  4. COVID-19 mRNA vaccination and all-cause mortality in the adult population in Norway during 2021–2023: a population-based cohort study BMJ Public Health (2026) primary study Strong

    In a Norwegian population-based cohort of 4,645,910 adults followed from January 2021 to December 2023, individuals who received three or more mRNA vaccine doses had a substantially lower adjusted all-cause mortality rate than unvaccinated individuals, with fully vaccinated adul…

    DOI: 10.1136/bmjph-2024-001859
  5. Effectiveness of COVID-19 Vaccination in Preventing All-Cause Mortality among Adults during the Third Wave of the Epidemic in Hungary: Nationwide Retrospective Cohort Study Vaccines (2022) primary study Strong

    In a nationwide retrospective cohort of 6.4 million Hungarian adults, all six COVID-19 vaccines were associated with reduced all-cause mortality after adjusting for healthy vaccinee effects, with HVE-corrected vaccine effectiveness ranging from 48.7% for Pfizer-BioNTech to 75.4%…

    DOI: 10.3390/vaccines10071009
  6. Is There a Link between the 2021 COVID-19 Vaccination Uptake in Europe and 2022 Excess All-Cause Mortality? Asian Pacific Journal of Health Sciences (2023) primary study Strong

    Analyses of 31 European countries found that higher 2021 COVID-19 vaccination uptake was associated with greater increases in monthly all-cause excess mortality during the first nine months of 2022, although the authors caution against causal interpretation and ecological fallac…

    DOI: 10.21276/apjhs.2023.10.1.6
  7. Age-specific patterns of all-cause mortality across COVID-19 booster dose groups in two Japanese municipalities: an exploratory analysis Frontiers in Public Health (2026) primary study Strong

    Exploratory analysis of Japanese municipal registry data found lower all-cause mortality among highly vaccinated adults aged 65-89 years but higher all-cause mortality among adults aged 20-49 years with ≥5 doses and those aged 50-64 with six doses, with causality unestablished.

    DOI: 10.3389/fpubh.2026.1795437
  8. Effectiveness of Inactivated COVID-19 Vaccination Against COVID-19–Related Hospitalization and Severe Outcomes in Adults ≥80 Years During Omicron Circulation in Beijing, China: Retrospective Cohort Study JMIR Public Health and Surveillance (2026) primary study Mixed

    During the 2022-2023 Beijing Omicron wave, booster vaccination in adults ≥80 years was associated with lower risk of COVID-19 hospitalization (VE 63.5%), severe/critical COVID-19 (66.9%), and in-hospital death (79.4%), though estimates may reflect residual confounding.

    DOI: 10.2196/82915

Your question next

What do you want to know?

No question is too uncomfortable for the evidence. Bring yours.

Ask your question →